ArticleFrontiers in endocrinology2025
Lightweight deep learning system for automated bone age assessment in Chinese children: enhancing clinical efficiency and diagnostic accuracy.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Automated MRI-based framework combining deep learning localization and machine learning classification for pubertal olecranon bone age assessment.International journal of legal medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone age assessment (BAA) is a critical diagnostic tool for evaluating skeletal maturity and monitoring growth disorders. Traditional clinical methods, however, are highly subjective, time-consuming, and reliant on clinician expertise, leading to inefficiencies and variability in accuracy. To address these limitations, this study introduces a novel lightweight two-stage deep learning framework based on the Chinese 05 BAA standard. In the first stage, the YOLOv8 algorithm precisely localizes 13 key epiphyses in hand radiographs, achieving a mean Average Precision (mAP) of 99.5% at Intersection over Union (IoU) = 0.5 and 94.0% within IoU 0.5-0.95, demonstrating robust detection performance. The second stage employs a modified EfficientNetB3 architecture for fine-grained epiphyseal grade classification, enhanced by the Rectified Adam (RAdam) optimizer and a composite loss function combining center loss and weighted cross-entropy to mitigate class imbalance. The model attains an average accuracy of 80.3% on the training set and 81.5% on the test set, with a total parameter count of 15.8 million-56-86% fewer than comparable models (e.g., ResNet50, InceptionV3). This lightweight design reduces computational complexity, enabling faster inference while maintaining diagnostic precision. This framework holds transformative potential for pediatric endocrinology and orthopedics by standardizing BAA, improving diagnostic equity, and optimizing resource use. Success hinges on addressing technical, ethical, and adoption challenges through collaborative efforts among developers, clinicians, and regulators. Future directions might include multimodal AI integrating clinical data (e.g., height, genetics) for holistic growth assessments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.